My Stocks Explore Events Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Live today
{{event.ticker}} @{{event.event_utc_datetime | date:'h:mm a'}}
{{market.market_short_name}} {{market.last_price | number : 2}}

Want to join the conversation?

$MAR {{ '2015-10-26T14:19:27+0000' | timeago}} • Announcement

In Conde Nast Traveler's 28th annual awards, $MAR's JW Marriott Hotels & Resorts has received 10 of the Readers' Choice Awards over an array of categories. Over 128,000 dedicated readers cast votes for over 5,000 hotels and resorts worldwide, with a select few being named to the coveted list.

User Melwyn Jones {{ '2016-10-28T17:16:30+0000' | timeago}}

$CVX posts first profit in a year. Right time to get some shares? My question is, will it sustain this turnaround?

User Josh Allan {{ '2016-10-27T15:39:01+0000' | timeago}}

Jeff Bezos, my inspiration next to Steve Jobs is going to review the Everything Store $AMZN's financial results today after hours. As an investor/user, I like Amazon Prime and it's success over several parts of the world. What's your take on Amazon?

User RC xNair {{ '2016-10-27T13:31:32+0000' | timeago}}

Of all the Wall St firms out there, Goldman Sachs $GS is the most revered for the way they're run - hiring the best, highly competitive, a closely-knit peer group and making tons of profits for the shareholders. An interesting interview of its CEO Llyod Blankfein by Carlyle groups chief David Rubenstein

User Ramesh Raju {{ '2016-10-27T10:38:07+0000' | timeago}}

Deutsche Bank posts Q3 net profit of 278 million euros.

User Vishnu Beri {{ '2016-10-27T01:52:28+0000' | timeago}}

Great results from $TSLA, however the question remains if Tesla can continue to scale up to produce the cars in the quantity it promises. Model 3 numbers need to be in multiples of what they are producing right now. Wish them the best, will keep an eye as I am still not convinced that they can scale easily.

$ALXN {{ '2016-10-28T17:56:17+0000' | timeago}} • Webcast

As providing Strensiq to more patients in the U.S. and extending global launch next year, $ALXN will continue to leverage its expertise in ultra-rare diseases to reach more patients with Hypophosphatasia (HPP), a disease that can damage bones and organs. $ALXN sees Strensiq to continue to be strong additional driver of growth in 2017 and beyond.

$AIV {{ '2016-10-28T17:53:15+0000' | timeago}} • Webcast

$AIV stated that the company always looks at development opportunities in its target markets. The company added that it currently does not have any development or lease up like investment opportunities in the immediate horizon.

$AIV {{ '2016-10-28T17:45:42+0000' | timeago}} • Webcast

$AIV commented that on the wind down of the affordable asset management business, the two components were; firstly, the amortization of deferred tax credit income and secondly, the operations of the properties itself. The company will try to sell those properties in the next few years, as the properties end its compliance periods.

$M {{ '2016-10-28T17:39:01+0000' | timeago}} • Announcement

$M's BoD declared a regular quarterly dividend of 37.75 cents per share on its common stock. The dividend is payable on Jan. 3, 2017 to shareholders of record on Dec. 15, 2016.

$AIV {{ '2016-10-28T17:33:06+0000' | timeago}} • Webcast

$AIV invested $44MM in its redevelopment activity, with $16MM in the continuation of projects being executed in phases, $10MM in new starts and the balance in smaller projects. On One Canal and Indigo properties, the company said it is well positioned for 4Q16 and 2017.